Samil Pharmaceutical Co.,Ltd (KRX:000520)

KRX:000520 Revenue

In the year 2024, Samil Pharmaceutical Co.,Ltd had annual revenue of 219.70B KRW with 11.89% growth. Samil Pharmaceutical Co.,Ltd had revenue of 57.79B in the quarter ending December 31, 2024, with 14.40% growth.

• Revenue: 219.70B
• Revenue Growth: +11.89%
• P/S Ratio: 0.93
• Revenue / Employee: 375.55M
• Employees: 585
• Market Cap: 240.96B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	219.70B	23.35B	11.89%
Dec 31, 2023	196.35B	16.67B	9.28%
Dec 31, 2022	179.68B	45.43B	33.84%
Dec 31, 2021	134.25B	11.25B	9.14%
Dec 31, 2020	123.00B	1.89B	1.56%